CVCA report finds life sciences, venture debt among bright spots in otherwise bleak H1 2025. Canadian venture capital (VC) market activity continued to decline in the first half of 2025 amid ongoing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results